Identification of a Damaging Subset of Neutrophils that Arises in Septic Patients
脓毒症患者中出现的破坏性中性粒细胞亚群的鉴定
基本信息
- 批准号:10179456
- 负责人:
- 金额:$ 50.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAnimalsBindingBloodBlood CirculationBlood VesselsBlood capillariesCell Differentiation processCellsCessation of lifeClinicalDiseaseEndothelial CellsEndotheliumExcisionFunctional disorderGeneticHeterogeneityHost DefenseHumanHyperactivityImmuneImmune responseImmune systemImmunosuppressionImpairmentIn VitroInfectionInfiltrationInflammatoryInjuryIntegrinsIntensive Care UnitsLaboratoriesLeadLifeLongitudinal StudiesLupusMacrophage-1 AntigenMalignant NeoplasmsMeasurementMediatingMediator of activation proteinMedicalMolecular TargetMorbidity - disease rateMusOrganPatientsPhenotypePlayPopulationPrognosisPublishingResearch DesignRoleSepsisSeverity of illnessSiteSourceSurfaceSystemTestingTimeTissuesantimicrobialarmattenuationbasecell injurycellular imagingcytokinedruggable targetexperimental studygranulocyteimproved outcomein vivointercellular cell adhesion moleculelongitudinal analysismigrationmortalitymultiphoton imagingneutrophiloverexpressionpathogenperipheral bloodpreservationpreventresponsesepticseptic patientstumor
项目摘要
ABSTRACT:
Sepsis is a “life-threatening organ dysfunction caused by a dysregulated host response to infection”.
Neutrophils become hyperactive during sepsis and they mediate much of the morbidity and mortality
associated with the disease. However the antimicrobial function of neutrophils provides benefit such that
depletion of the entire population of neutrophils in the septic patient would be immunosuppressive.
Heterogeneity of neutrophils has recently been described in disease states including cancer and lupus. Our
laboratories have discovered the presence of a small population of bloodstream neutrophils that overexpress
the integrin VLA3 (CD49c/CD29; a3b1) in ICU patients and experimental animals with sepsis. We have shown
that blockade or genetic depletion of neutrophil VLA3 has a survival advantage in septic mice. These findings
indicate that selective removal of the VLA3high subset improves outcome without impairment of innate host
defense against infection. In humans, neutrophils from septic patients demonstrate pronounced damage to the
barrier function of endothelial cells in vitro which is prevented by VLA3 blocking. This suggests that the primary
target of damage to the septic host by VLA3high cells is the vasculature. In addition, preliminary evidence also
shows that septic patients that have VLA3high neutrophils late into the disease have increased mortality as
compared to patients who do not show VLA3high cells in their blood. The overarching hypothesis to be
tested in this proposal is that a distinct, hyperinflammatory and damaging subset of blood neutrophils,
which express high levels of VLA3, arises in the circulation of ICU patients with sepsis. It is
hypothesized further that the presence of circulating VLA3high neutrophils predicts severity of the disease as
determined by clinical scoring, and that VLA3 represents a druggable target for attenuation of inflammatory
damage to the septic patient while avoiding overt immunosuppression. Three specific aims are put forth to test
these hypotheses. Aim 1 will determine the correlation between VLA3 expression and activation on peripheral
blood neutrophils and illness severity in septic ICU patients. Aim 2 will use human cells and multiphoton
imaging of septic mice to test the hypothesis that VLA3high neutrophils comprise a hyperinflammatory subset
that causes vascular damage and capillary leak. Aim 3 will characterize the VLA3high and VLA3low neutrophil
subsets and examine the mechanisms through which they impair endothelial barrier function. Taken together,
this proposal addresses mechanisms regarding how the dysregulated host response threatens patient survival
and offers a molecular target for dampening the destructive arms of the hyperinflammatory response while
preserving the beneficial aspects of immune defense.
摘要:
脓毒症是“由宿主对感染的反应失调引起的危及生命的器官功能障碍”。
中性粒细胞在脓毒症中变得过度活跃,它们介导了许多发病率和死亡率
与疾病有关。然而,嗜中性粒细胞的抗微生物功能提供了益处,
脓毒症患者中整个嗜中性粒细胞群体的耗竭将是免疫抑制性的。
近来在包括癌症和狼疮的疾病状态中描述了嗜中性粒细胞的异质性。我们
实验室已经发现存在少量的血液中性粒细胞,
ICU患者和脓毒症实验动物中整合素VLA 3(CD 49 c/CD 29; a3 b1)。我们已经表明
中性粒细胞VLA 3的阻断或基因耗竭在脓毒症小鼠中具有存活优势。这些发现
表明选择性去除VLA 3高亚群改善了结果而不损害先天宿主
防御感染。在人类中,来自脓毒症患者的中性粒细胞表现出对
通过VLA 3阻断阻止体外内皮细胞的屏障功能。这表明,主要
VLA 3 high细胞对脓毒症宿主的损伤靶点是脉管系统。此外,初步证据还显示,
表明,在疾病晚期具有VLA 3高中性粒细胞的脓毒症患者死亡率增加,
与血液中未显示VLA 3 high细胞的患者相比。总体假设是
在这个提议中测试的是一个独特的,高度炎症和破坏性的血液中性粒细胞亚群,
其表达高水平的VLA 3,在ICU脓毒症患者的循环中出现。是
进一步假设循环中VLA 3高中性粒细胞的存在预测疾病的严重程度,
通过临床评分确定,并且VLA 3代表了用于减轻炎症性细胞因子的可药物化靶点。
同时避免明显的免疫抑制。提出了三个具体的目标来检验
这些假设。目的1将确定VLA 3表达与外周血淋巴细胞活化之间的相关性。
败血症ICU患者的血液中性粒细胞和疾病严重程度。AIM 2将使用人类细胞和多光子
脓毒症小鼠的成像,以检验VLA 3高中性粒细胞包含高度炎症亚群的假设
导致血管损伤和毛细血管渗漏目的3将表征VLA 3高和VLA 3低中性粒细胞
亚群,并检查其损害内皮屏障功能的机制。综合起来看,
这一建议涉及宿主反应失调如何威胁患者生存的机制
并提供了一个分子靶点,用于抑制过度炎症反应的破坏性武器,
保护免疫防御的有益方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Minsoo Kim其他文献
Minsoo Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Minsoo Kim', 18)}}的其他基金
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10515703 - 财政年份:2022
- 资助金额:
$ 50.4万 - 项目类别:
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10643889 - 财政年份:2022
- 资助金额:
$ 50.4万 - 项目类别:
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10832821 - 财政年份:2022
- 资助金额:
$ 50.4万 - 项目类别:
Functional genomic investigation of complement signaling in the human brain
人脑补体信号传导的功能基因组研究
- 批准号:
10389218 - 财政年份:2021
- 资助金额:
$ 50.4万 - 项目类别:
Visualizing the resolution of innate immune responses during influenza infection
可视化流感感染期间先天免疫反应的解决
- 批准号:
10084273 - 财政年份:2020
- 资助金额:
$ 50.4万 - 项目类别:
Visualizing the resolution of innate immune responses during influenza infection
可视化流感感染期间先天免疫反应的解决
- 批准号:
9899365 - 财政年份:2020
- 资助金额:
$ 50.4万 - 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
- 批准号:
10646491 - 财政年份:2019
- 资助金额:
$ 50.4万 - 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
- 批准号:
9981638 - 财政年份:2019
- 资助金额:
$ 50.4万 - 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
- 批准号:
9814149 - 财政年份:2019
- 资助金额:
$ 50.4万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 50.4万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 50.4万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 50.4万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 50.4万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 50.4万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 50.4万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 50.4万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 50.4万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 50.4万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 50.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists